SpringWorks Therapeutics(SWTX) - 2024 Q2 - Earnings Call Presentation

Q2 2024 Financial Results and Business Update August 7, 2024 之 Spring 2 Today's Agenda | --- | --- | |----------------------------|--------------------------------------------| | Sections | Presenter(s) | | Opening Remarks | Saqib Islam Chief Executive Officer | | OGSIVEO for Desmoid Tumors | Bhavesh Ashar Chief Commercial Officer | | Mirdametinib for NF1-PN | Jim Cassidy, MD, PhD Chief Medical Officer | | Financial Results | Frank Perier, Jr. Chief Financial Officer | | Looking Ahead | Saqib Islam Chief Ex ...